Compass Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Compass Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Compass Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Compass Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $694k | 198k | 3.50 |
| 2025-06-30 | $685k | 264k | 2.60 |
| 2025-03-31 | $290k | 153k | 1.90 |
| 2024-12-31 | $237k | 164k | 1.45 |
| 2024-09-30 | $120k | 65k | 1.84 |
| 2024-06-30 | $50k | 50k | 1.00 |
| 2024-03-31 | $218k | 110k | 1.98 |
| 2023-12-31 | $160k | 103k | 1.56 |
| 2023-09-30 | $116k | 59k | 1.97 |
| 2023-06-30 | $199k | 63k | 3.18 |
| 2023-03-31 | $25k | 7.7k | 3.27 |
| 2022-12-31 | $60k | 12k | 5.03 |
| 2022-09-30 | $16k | 7.2k | 2.21 |
| 2022-06-30 | $19k | 7.2k | 2.63 |
| 2022-03-31 | $10k | 7.2k | 1.38 |
| 2021-12-31 | $23k | 7.2k | 3.18 |